Page last updated: 2024-10-31

midazolam and Meningeal Neoplasms

midazolam has been researched along with Meningeal Neoplasms in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Meningeal Neoplasms: Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Massei, R1
Baratta, P1
Beretta, L1
de Silva, E1
Tomei, G1
Gaini, SM1
Rampini, P1

Other Studies

1 other study available for midazolam and Meningeal Neoplasms

ArticleYear
[Variations of intracranial pressure during induction with midazolam].
    Minerva anestesiologica, 1985, Volume: 51, Issue:10

    Topics: Adenoma; Adult; Anesthetics; Benzodiazepines; Brain Neoplasms; Cranial Nerve Neoplasms; Craniopharyn

1985